Year: 2023
Type: review
Abstract: In recent decades, diabetes mellitus (DM) has become a major global health problem owing to its high prevalence and increased incidence of diabetes-associated complications, including diabetic wounds (DWs), diabetic nephropathy, metabolic syndrome, diabetic retinopathy, and diabetic neuropathy. In both type 1 and type 2 diabetes, tissue damage is organ-specific, but closely related to the overproduction of reactive oxygen species (ROS) and hyperglycaemia-induced macrovascular system damage. However, existing therapies have limited effects on complete healing of diabetic complications. Fortunately, recent advances in functional nucleic acid materials have provided new opportunities for the treatment and diagnosis of diabetic complications. Functional nucleic acids possess independent structural functions that can replace traditional proteases and antibodies and perform specific biological non-genetic functions. This review summarises the current functional nucleic acid materials reported for the treatment of diabetic complications, including tetrahedral framework nucleic acids (tFNAs), short interfering RNA (siRNA), micorRNA (miRNA), locked nucleic acids, antisense oligonucleotides (ASOs), and DNA origami, which may assist in the development of novel nucleic acids with new functions and capabilities for better healing of diabetic complications.
Source: Nanoscale Advances
DOI: 10.1039/d3na00327b
Institutions: Sichuan University, State Key Laboratory of Oral Diseases
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: functional nucleic acids, diabetes complications, tetrahedral framework nucleic acids, siRNA, microRNA, locked nucleic acid, antisense oligonucleotides, DNA origami, diabetic wounds, diabetic nephropathy, diabetic retinopathy, diabetic neuropathy, reactive oxygen species, hyperglycemia, macrovascular damage, wound healing
Open Access status: gold
Estimated APC paid: $1,962
OpenAlex ID: W4386234972
